| scholarly article | Q13442814 |
| P2093 | author name string | Mariano T Mesngon | |
| Danielle L Ippolito | |||
| Peter G Napolitano | |||
| Brad M Dolinsky | |||
| Deborah Tinnemore | |||
| Monica A Lutgendorf | |||
| Mary Jo Dehart | |||
| P2860 | cites work | NIH Image to ImageJ: 25 years of image analysis | Q23319322 |
| Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus | Q24241616 | ||
| Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis | Q28138808 | ||
| Myosin-X functions in polarized epithelial cells | Q30513859 | ||
| Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features | Q30751916 | ||
| A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy | Q33577192 | ||
| Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. | Q33896064 | ||
| In vitro model for evaluating drug transport across the blood-brain barrier | Q33904239 | ||
| Permeability of bovine brain microvessel endothelial cells in vitro: barrier tightening by a factor released from astroglioma cells | Q33969609 | ||
| Intrauterine infection and the development of cerebral palsy | Q34199341 | ||
| Isoflurane induces endothelial apoptosis of the post-hypoxic blood-brain barrier in a transdifferentiated human umbilical vein endothelial cell model | Q34313836 | ||
| Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. | Q34419230 | ||
| Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy | Q34434035 | ||
| High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia | Q34438540 | ||
| Antenatal steroids are associated with a reduction in the incidence of cerebral white matter lesions in very low birthweight infants | Q35291746 | ||
| Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis | Q35842988 | ||
| The role of cytokines and inflammatory cells in perinatal brain injury | Q35864361 | ||
| Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. | Q36166111 | ||
| Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. | Q36283990 | ||
| The matrix metalloproteinases (MMPS) in the decidua and fetal membranes | Q36664406 | ||
| Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances | Q37253850 | ||
| Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury | Q37393237 | ||
| Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism | Q37448003 | ||
| Periventricular white matter damage in the hypoxic neonatal brain: role of microglial cells | Q37476119 | ||
| Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dose | Q37585003 | ||
| Association of cord blood magnesium concentration and neonatal resuscitation | Q37721256 | ||
| Matrix metalloproteinases and neurotrauma: evolving roles in injury and reparative processes | Q37733211 | ||
| Inflammation and early brain injury in term and preterm infants. | Q38026568 | ||
| Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes | Q38360811 | ||
| The effect of magnesium sulfate on the activity of matrix metalloproteinase-9 in fetal cord plasma and human umbilical vein endothelial cells | Q39666106 | ||
| Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND. | Q40167696 | ||
| A comparison of the induction of immortalized endothelial cell impermeability by astrocytes | Q40801825 | ||
| Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. | Q40903073 | ||
| Cell-cell contacts in the human cell line ECV304 exhibit both endothelial and epithelial characteristics | Q40943179 | ||
| Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood-brain barrier | Q41209287 | ||
| Maternal Intrauterine Infection, Cytokines, and Brain Damage in the Preterm Newborn | Q41522259 | ||
| Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy? | Q42436407 | ||
| Endotoxin-activated microglia injure brain derived endothelial cells via NF-κB, JAK-STAT and JNK stress kinase pathways. | Q42701827 | ||
| 3D reconstruction of histological sections: Application to mammary gland tissue | Q43627438 | ||
| The fetal inflammatory response syndrome. | Q44994885 | ||
| Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*. | Q46340488 | ||
| Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial | Q47351196 | ||
| Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection | Q48377741 | ||
| Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants | Q48476496 | ||
| Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NFkappaB pathway | Q48665603 | ||
| Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia | Q48809957 | ||
| Histologic chorioamnionitis and umbilical serum levels of pro-inflammatory cytokines and cytokine inhibitors. | Q51713717 | ||
| Antenatal steroids may reduce adverse neurological outcome following chorioamnionitis: neurodevelopmental outcome and chorioamnionitis in premature infants. | Q51931421 | ||
| Immunohistochemical expression of tumor necrosis factor alpha in neonatal leukomalacia. | Q52011429 | ||
| Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier. | Q52510320 | ||
| Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants | Q57837984 | ||
| Determination of Plasma Dexamethasone in the Mother and the Newborn after Administration of the Hormone in a Clinical Trial | Q70237169 | ||
| Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes | Q71064339 | ||
| Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes | Q72414034 | ||
| Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1 alpha/beta, tumor necrosis factor-alpha and interferon-gamma | Q72802695 | ||
| Amniotic fluid concentrations of interleukin-1beta, interleukin-6 and TNF-alpha in chorioamnionitis before 32 weeks of gestation: histological associations and neonatal outcome | Q78059916 | ||
| Association between high cytokine levels with white matter injury in preterm infants with sepsis | Q84341078 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P921 | main subject | magnesium | Q660 |
| blood–brain barrier | Q221694 | ||
| inflammation | Q101991 | ||
| magnesium sulfate | Q288266 | ||
| dexamethasone | Q422252 | ||
| magnesium sulfate | Q18212318 | ||
| P304 | page(s) | 483-491 | |
| P577 | publication date | 2013-09-27 | |
| P1433 | published in | Reproductive Sciences | Q7314305 |
| P1476 | title | Effect of dexamethasone administered with magnesium sulfate on inflammation-mediated degradation of the blood-brain barrier using an in vitro model | |
| P478 | volume | 21 |
| Q41098474 | Antenatal factors modulate hearing screen failure risk in preterm infants |
| Q87870397 | Blood brain barrier (BBB)-disruption in intracortical silicon microelectrode implants |
| Q93136005 | Human ES-derived MSCs correct TNF-α-mediated alterations in a blood-brain barrier model |
| Q36102790 | Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants |
| Q41374680 | LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention |
| Q37602559 | Permeability across a novel microfluidic blood-tumor barrier model |
Search more.